Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Colorado · 2026 Regular Session · Bill

SB 130: Medical Spas Deceptive Trade Practices

Introduced Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 130 is a bill introduced in the Colorado Senate on February 25, 2026. According to its official title, it concerns: Medical Spas Deceptive Trade Practices. Primary sponsor: Sheila Lieder (Democratic), Cathy Kipp (Democratic), Lisa Frizell (Republican). Most recent recorded action (April 23, 2026): Senate Committee on Health & Human Services Postpone Indefinitely.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

The bill makes it an unfair or deceptive trade practice under the "Colorado Consumer Protection Act" for a facility or medical practice providing cosmetic, aesthetic, wellness, longevity, or lifestyle treatments involving the administration or use of prescription drugs, including injectable and sterile drug products (medical spa), to:Acquire or receive a prescription drug from a person not legally authorized to distribute or transfer the prescription drug;Fail to store, handle, prepare, or administer a prescription drug in accordance with manufacturer requirements, applicable federal and state law, or generally accepted standards of medical practice;Permit an individual to prescribe or administer prescription drugs outside the scope of the individual's state-issued credential;Fail to maintain reasonable safeguards to prevent contamination, diversion, theft, or misuse of prescription drugs;Represent that a prescription drug is safe or effective in a manner inconsistent with federal law or federal food and drug administration-approved labeling; has sponsorship, approval, characteristics, ingredients, uses, or benefits that it does not have; or is approved by the federal food and drug administration when it is not;Fail to designate a licensed health-care provider with prescriptive authority to provide clinical oversight of prescription drugs used at the medical spa; orFail to create, maintain, or produce to the attorney general or a district attorney records of serious adverse events involving patients.The attorney general or a district attorney may enforce a violation of a prohibited action specified in the bill. The attorney general may adopt rules to implement the bill.(Note: This summary applies to this bill as introduced.)

Sponsors

Sponsors by party (alphabetical): Democratic 2 · Republican 1

NameRolePartyChamberDistrict
Sheila LiederPrimary sponsorDemocraticHouse28
Cathy KippPrimary sponsorDemocraticSenate14
Lisa FrizellPrimary sponsorRepublicanSenate2

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Senate Committee on Health & Human Services Postpone Indefinitely
  2. Introduced In Senate - Assigned to Health & Human Services

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source